Bio-Technology Department
: [569]
Community home page
Recent Submissions
THE P53/SOX2 AXIS IN MODULATING THE CELL FATE IN NEURONS: A PARADIGM OF NEURODEGENERATION AND BRAIN TUMORS
See
IN SILICO DISCOVERY OF NEW INHIBITORS TARGETING HIV-1 REVERSE TRANSCRIPTASE: EXPLORING NOVEL APPROACHES FOR ANTIRETROVIRAL THERAPY
See
IMPACT OF PHOSPHINE ON QUALITY PARAMETERS OF STORED PERISHABLE COMMODITIES
See
EVALUATION OF PHYTOCHEMICALS FROM TINOSPORA CORDIFOLIA AGAINST ONCOGENIC AND RESISTANCE-ASSOCIATED TARGETS IN LOW-GRADE SEROUS OVARIAN CARCINOMA
See
COMPARATIVE ANALYSIS OF MACHINE LEARNING AND DEEP LEARNING MODELS FOR PLANT DISEASE DETECTION
See
SYNERGIZING PHYTOCHEMICAL PHARMACOLOGY AND PRECISION GENE EDITING FOR MULTIMODAL AUTISM SPECTRUM DISORDER INTERVENTION
See
INTEGRATIVE COMPUTATIONAL FRAMEWORK FOR DOPAMINE D3 RECEPTOR-TARGETED DRUG DISCOVERY: BRIDGING GENETIC VARIABILITY, STRUCTURAL DYNAMICS, AND MACHINE LEARNING
See
DIABETIC RETINOPATHY DETECTION USING CONVOLUTIONAL NEURAL NETWORKS: A DEEP LEARNING APPROACH
See
INTEGRATIVE IN SILICO DRUG DISCOVERY: TARGETING TYROSINASE WITH NATURAL COMPOUNDS FOR THERAPEUTIC MANAGEMENT OF VITILIGO
See
LYNX-RNA: A NEXTFLOW-BASED MODULAR RNA-SEQ AND MACHINE LEARNING PIPELINE FOR BIOMARKER DISCOVERY WITH LLM-SUMMARIZED REPORT GENERATION IN IMMUNE THROMBOCYTOPENIA
See
INTERPRETABLE ENSEMBLE LEARNING PREDICTS GLIOBLASTOMA SENSITIVITY TO NATURAL COMPOUNDS
See
INTEGRATIVE COMPUTATIONAL APPROACHES FOR RECEPTOR-BASED DRUG DISCOVERY AND BIOMARKER IDENTIFICATION IN NDDs
See
INTEGRATED MULTI-OMICS APPROACHES TO INVESTIGATE THE ROLE OF THE GUT MICROBIOME IN HUMAN HEALTH
See
EXPLORING NATURAL COMPOUNDS AS SAFER ALTERNATIVES OF CONVENTIONAL DRUGS FOR NON-SMALL CELL LUNG CANCER
See
IDENTIFICATION OF NATURAL BRAF INHIBITORS AS POTENTIAL ALTERNATIVES TO DABRAFENIB: AN IN SILICO STUDY
See
IN-SILICO INVESTIGATION OF TOXICITY AND FUNGAL LACCASE MEDIATED BIODEGRADATION OF BISPHENOL A AND PHTHALATE ESTERS
See
IN SILICO ANALYSIS OF PROTEIN-EXCIPIENT INTERACTIONS: A MOLECULAR DOCKING STUDY ON THERAPEUTIC IL-11
See
IN SILICO INVESTIGATION OF PHYTOCHEMICALS DERIVED FROM CATHARANTHUS ROSEUS AS POTENTIAL THERAPEUTIC AGENTS TARGETING THE A42R PROTEIN OF THE HUMAN MONKEYPOX VIRUS
See
IN SILICO APPROACH, TO STUDY THE PHYTOCHEMICALS PRESENT IN CAMELLIA SINENSIS AND WITHANIA SOMNIFERA TO TARGET MPXV VIRUS A42R FOR THE TREATMENT OF MONKEYPOX DISEASE
See